- Home
- GBDC vs PCVX Comparison
GBDC vs PCVX Comparison
Compare GBDC & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBDC
- PCVX
- Stock Information
- Founded
- GBDC 2009
- PCVX 2013
- Country
- GBDC United States
- PCVX United States
- Employees
- GBDC N/A
- PCVX N/A
- Industry
- GBDC Finance: Consumer Services
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- GBDC Finance
- PCVX Health Care
- Exchange
- GBDC Nasdaq
- PCVX Nasdaq
- Market Cap
- GBDC 3.7B
- PCVX 4.0B
- IPO Year
- GBDC 2010
- PCVX 2020
- Fundamental
- Price
- GBDC $14.09
- PCVX $45.28
- Analyst Decision
- GBDC Buy
- PCVX Strong Buy
- Analyst Count
- GBDC 3
- PCVX 8
- Target Price
- GBDC $15.00
- PCVX $114.17
- AVG Volume (30 Days)
- GBDC 2.0M
- PCVX 1.6M
- Earning Date
- GBDC 11-18-2025
- PCVX 11-05-2025
- Dividend Yield
- GBDC 11.52%
- PCVX N/A
- EPS Growth
- GBDC N/A
- PCVX N/A
- EPS
- GBDC 1.41
- PCVX N/A
- Revenue
- GBDC $877,342,000.00
- PCVX N/A
- Revenue This Year
- GBDC $23.63
- PCVX N/A
- Revenue Next Year
- GBDC N/A
- PCVX N/A
- P/E Ratio
- GBDC $9.97
- PCVX N/A
- Revenue Growth
- GBDC 31.97
- PCVX N/A
- 52 Week Low
- GBDC $12.68
- PCVX $27.66
- 52 Week High
- GBDC $16.01
- PCVX $116.00
- Technical
- Relative Strength Index (RSI)
- GBDC 51.88
- PCVX 66.85
- Support Level
- GBDC $13.74
- PCVX $43.12
- Resistance Level
- GBDC $14.33
- PCVX $45.69
- Average True Range (ATR)
- GBDC 0.24
- PCVX 1.67
- MACD
- GBDC 0.04
- PCVX -0.12
- Stochastic Oscillator
- GBDC 66.43
- PCVX 90.79
About GBDC Golub Capital BDC Inc.
Golub Capital BDC Inc is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in United States middle-market companies. It also invests in the second lien and subordinated loans, warrants, and minority equity securities in United States middle-market companies. The company generally invests in securities that have been rated below investment grade by independent rating agencies or that would be rated below investment grade if rated. Maximum investment is done in USA and Canadian Companies, with maximum profit earned from those countries.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.